NIH: Fogarty International Center NIH: Fogarty International Center
Advancing Science for Global Health
Advancing Science for Global Health
Home > Funding > Funding Newsletter for Global Health Researchers > Funding Newsletter for Global Health Researchers - Week of September 9, 2019 Print

Funding Newsletter for Global Health Researchers - Week of September 9, 2019

On behalf of the Fogarty International Center at the U.S. National Institutes of Health (NIH), the following funding opportunities, notices and announcements may be of interest to those working in the field of global health research. Updates are typically distributed once a week.

Funding Opportunities

NIH funding opportunities for which foreign organizations, foreign components of U.S. organizations and/or other foreign components may apply.

Funding News

NIH funding news that may be relevant to global health researchers.

  • Notice of Special Interest: Research to Improve Pre-Pregnancy Care and Enhance Healthy Birth Intervals (NOT-HD-19-019)
    Note: Encourages cross-disciplinary and multi-level studies, domestic and international study sites, and research focused on understudied and vulnerable populations.
  • Notice of Intent to Publish a Funding Opportunity Announcement for the Pediatric HIV AIDS Cohort Study Program Project Grant Applications (P01 Clinical Trial Not Allowed) (NOT-HD-19-024)
  • Notice of Special Interest: Mechanisms Underlying the Contribution of Sleep Disturbances to Pain (NOT-HD-19-020)
  • The National Institutes of Health (NIH) Sexual & Gender Minority Research Office (SGMRO) Announces Mid-Atlantic Regional Workshop on Sexual and Gender Minority (SGM)-Related Health Research (NOT-OD-19-142)
  • Notice of Change to Information relevant to Specific Institutes/Centers in Dissemination and Implementation Research in Health PAR-19-274 (R01 Clinical Trial Optional) (NOT-AR-19-040) and PAR-19-275 (R21 Clinical Trial Optional) (NOT-AR-19-041)
  • Notice to Extend Research on Autism Spectrum Disorders PA-18-401 (R01-Clinical Trial Optional) (NOT-MH-19-046) and PA-18-399 (R03-Clinical Trial Optional) (NOT-MH-19-047)

Upcoming Deadlines